Hyperlipidemia Type 3 Latest Advances

Find the Latest Research About Hyperlipidemia Type 3

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 724 publications

Genetic dyslipidemias.

Genetic dyslipidemias.

Journal: Annales d'endocrinologie
Published: March 22, 2026

APOB to estimated APOB ratio for screening for the APOE2 genotype.

APOB to estimated APOB ratio for screening for the APOE2 genotype.

Journal: medRxiv : the preprint server for health sciences
Published: February 26, 2026

Severe hypertriglyceridemia due to heterozygous LPL variant, ApoE ε2ε2 genotype, and environmental interactions in an 11-year-old boy.

Severe hypertriglyceridemia due to heterozygous LPL variant, ApoE ε2ε2 genotype, and environmental interactions in an 11-year-old boy.

Journal: Journal of clinical lipidology
Published: February 06, 2026

Lipoprotein apheresis as rescue therapy in lipoprotein glomerulopathy: The role of plasmatic extracellular vesicle removal.

Lipoprotein apheresis as rescue therapy in lipoprotein glomerulopathy: The role of plasmatic extracellular vesicle removal.

Journal: Journal of clinical lipidology
Published: November 27, 2025

Risk of Atherosclerotic Cardiovascular Disease in Familial Remnant Hyperlipidemia (Dysbetalipoproteinemia) and Familial Hypercholesterolemia.

Risk of Atherosclerotic Cardiovascular Disease in Familial Remnant Hyperlipidemia (Dysbetalipoproteinemia) and Familial Hypercholesterolemia.

Journal: Journal of the American College of Cardiology
Published: October 09, 2025

Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.

Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.

Journal: Journal of the American Heart Association
Published: August 23, 2025

Diagnosis of familial dysbetalipoproteinemia due to APOE p.(Arg154Ser): The role of ultracentrifugation and lipid ratios.

Diagnosis of familial dysbetalipoproteinemia due to APOE p.(Arg154Ser): The role of ultracentrifugation and lipid ratios.

Journal: Journal of clinical lipidology
Published: July 09, 2025

Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study.

Genetic and Metabolic Factors of Familial Dysbetalipoproteinemia Phenotype: Insights from a Cross-Sectional Study.

Journal: International journal of molecular sciences
Published: June 18, 2025

Letter to the Editor From Xu and Lu: "Predictors of Cardiovascular Disease in Individuals With Dysbetalipoproteinemia: A Prospective Study in the UK Biobank".

Letter to the Editor From Xu and Lu: "Predictors of Cardiovascular Disease in Individuals With Dysbetalipoproteinemia: A Prospective Study in the UK Biobank".

Journal: The Journal of clinical endocrinology and metabolism
Published: June 04, 2025

Dysbetalipoproteinaemia in genetically predisposed Ghanaians.

Dysbetalipoproteinaemia in genetically predisposed Ghanaians.

Journal: Lipids in health and disease
Published: May 26, 2025

Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III.

Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III.

Journal: Biochemistry and biophysics reports
Published: April 11, 2025

The Challenges of Diagnosing Familial Dysbetalipoproteinemia: A Case Associated With a Rare ApoE Variant.

The Challenges of Diagnosing Familial Dysbetalipoproteinemia: A Case Associated With a Rare ApoE Variant.

Journal: Case reports in medicine
Published: February 20, 2025
Showing 1-12 of 724

Last Updated: 06/30/2026